

Always in the frontline for benefits in preventive medicine
The primary aim of R&D activity at Fluart is to meet and even overachieve the registration criteria of influenza vaccines to ensure the best possible quality to protect human lives against disease.
-
Besides the continuous flu related R&D Fluart is involved in several innovative areas of different vaccine developments, both of manufacturing and administration aspects, as well as in addressing diverse viral and bacterial challenging pathogens.